wt./5 ml, in a Polytron P 10 homogenizer, in a solubilizing buffer containing 1 M-NaCI, 5Om~-Tris/HC1 buffer, O .~~M -E D T A and 0.5% Triton X-100 at pH7.3. The homogenates were kept for 1 h on ice before centrifugation at 15 OOOg for 20min at 4OC in an MSE Superspeed 50 centrifuge. The pellets were resuspended and the centrifugation procedure was repeated three times. The supernatants were combined, centrifuged at 30000g for 30min at 4OC and the acetylcholinesterase activity (Ellman et al., 1961) and total protein (Lowry et al., 1951) of the supernatants were determined. Samples ( 2 0 0~1 ) were layered on to continuous 5-20% (w/v) sucrose density gradients (13.5m1, tube length 95mm) and centrifuged in a Beckmann L5-65 centrifuge at 182850ga,, (38000rev./min) for 18.5 h at 2OC. Gradients were calibrated by using /I-galactosidase (EC 3.2.1.23) (sedimentation coefficient 16.14s; Kuby & Lardy, 1953) and alcohol dehydrogenase (EC 1.1.1.1) (sedimentation coefficient 4.8s; Vallee & Hoch, 1955) as marker enzymes. Fractions were incubated at a final concentration of 0.252pg of protein/ml with pig /I-endorphin or an equivalent volume of buffer for 20 min before determination of acetylcholinesterase activity. At 0.1 PM /I-endorphin decreased the activity of the 16 S form by over 50% (P(O.01; Fig. la ). In the range 0.1 nM-1 pM-/I-endorphin produced a concentration-dependent inhibition of 16 S acetylcholinesterase, the maximum effect being observed at 0.1 ,UM concentration (Fig. lb) . Fractions containing peaks of activity of the 1 1 S and 4 S forms of the enzyme were pooled and the enzyme activity was measured in the presence of 0.1 pM-/I-endorphin. No significant change in the activity of these forms (n = 4-9, P > 0.2) was apparent.
/I-Endorphin thus selectively inhibits the 1 6 s form of acetylcholinesterase, which is localized exclusively at the neuromuscular junction in the rat (Hall, 1973) . The presence in motor nerves of this or a closely related peptide during development (Haynes et al., 1980, and unpublished work) suggests that it may even be partly responsible for the low activity of this form of the enzyme seen in immature muscle tissue.
Bloom, F., Battenberg, E., Rosier, J., Ling, N. & Guillemin. R. Studies of the correlation of neurochemical and behavioural effects of lead in animals are both contradictory and inadequate, although several authors have suggested that whole-brain catecholamines are increased in lead-exposed animals (Shih & Hasin, 1978) .
The present study has therefore centred on the neurochemical correlates of lead exposure in the rat, which have been investigated not only by measurement of steady-state concentrations of catecholamines, but also by measurement of the more dynamic indices, the activity of catecholaminesynthesizing enzymes.
Acute and chronic studies were carried out in male Wistar rats weighing 1OOg. In the acute studies three groups of six rats each were treated daily for 14 days with intraperitoneal injections of either saline (0.9% NCI) for controls or lead (as 595th MEETING, MANCHESTER acetate) at doses of 5 and 20pmol/kg body wt. In the chronic studies animals were treated in groups of six, for either 8 or 26 weeks, with lead added to their drinking water at a concentration of 2 m~. Control animals received tap water whose lead concentration was known to be less than 2 0 n~. The doses of lead were selected on the basis of previous studies that had shown them to result in behavioural changes in neonatal animals.
The animals were starved of food for 24 h before being killed, but provided with water ad libitum. The animals were killed by decapitation and their brains immediately excised and divided by free hand section into the following regions: cerebral cortex, brain stem, hippocampus and anterior and posterior hypothalamus. Brain regions were arbitrarily selected to give representation of functional and neurochemical areas. The concentrations of lead were measured in the various brain regions by flameless atomic-absorption spectrophotometry. The catecholamines noradrenaline, adrenaline and dopamine were measured by the catechol 0-methyltransferase radioenzymic assay of de Prada & Zurcher (1976) . The activity of the rate-limiting enzyme of catecholamine synthesis, tyrosine hydroxylase (EC 1.14.16.2), and the activity of phenylethanolamine N-methyltransferase (EC 2.1.1.28). which has been proposed as the rate-limiting enzyme of adrenaline synthesis, were determined by radiometric assays (Petty & Reid, 1979) . Results were analysed by repeated measures analysis of variance.
Lead concentrations were elevated in all brain regions in lead-treated animals. There were, however, significant differences in the inter-regional distribution of lead in the brain tissue examined.
In the cerebral cortex, brain stem and hippocampus no significant changes in steady-state concentrations of catecholamines and catecholamine-synthesizing enzymes associated with lead exposure were observed. In the anterior hypothalamus acute exposure to lead was associated with a decrease in tyrosine hydroxylase, which was paralleled by significant increases in steady-state concentrations of all three catecholamines (Table I) . Similar results were obtained in the posterior hypothalamus. In chronic exposure the activity of tyrosine hydroxylase in the anterior hypothalamus was decreased by lead exposure (Table 1 ). The steady-state concentrations of noradrenaline and dopamine were, however, significantly lower in the animals treated chronically for 20 weeks when compared with their controls (Table 1) . As with the acute experiments the results in the posterior hypothalamus paralleled those in the anterior hypothalamus.
In conclusion it is clear that lead ingestion at concentrations known to result in behavioural effects are associated with localized neurochemical effects on the hypothalamus. This may reflect a decrease in noradrenaline turnover and thus neuronal activity and may therefore have mechanistic and therapeutic relevance in clinical lead poisoning. U.K. Morgan, 1971; Saavedra et al., 1973) , where it may be a contributing factor in the pathogenesis of schizophrenia (Rodnight, 1980) . If the existence of this enzyme in cerebral tissue were to be firmly established, then it would mean that NN-dimethyltryptamine would fulfil most of the Hollister's criteria for an endogenous psychotoxin (Gillin et al., 1976) . However, the brain N-methyltransferase assay method is unsatisfactory because it fails to differentiate between enzymic methylation and a non-enzymic Pictet-Spengler condensation between the substrate and formaldehyde presumably derived from hydrolysis of the methyl donor (Boarder & Rodnight, 1976; Boarder et al., 1976; Gomes et al., 1976; Rosengarten et al., 1976; Oon et al., 1977; Stramentinoli & Baldessarini, 1978) .
In this radioenzymic assay method S-adenosyl-L-[ Me-14C lmethionine is incubated with tryptamine, and the labelled methylated indolylamines are extracted into toluene/3-methyl-
